Lyme nephritis

Journal of Veterinary Emergency and Critical Care

Volumn 23, Issue 2, 2013, Pages 163-173

  Littman, Meryl P ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Autoimmunity; Borrelia burgdorferi; Borreliosis; Glomerulonephritis; Protein losing nephropathy; Retriever

Indexed keywords

ANIMAL; ANIMAL DISEASE; HUMAN; LYME DISEASE; NEPHRITIS; PATHOLOGY; REVIEW;

ANIMALS; HUMANS; LYME DISEASE; NEPHRITIS;

BORRELIA; BORRELIA BURGDORFERI; CANIS FAMILIARIS;

EID: 84876127582     PISSN: 14793261     EISSN: 14764431     Source Type: Journal    
DOI: 10.1111/vec.12026     Document Type: Review

References (88)

1. Littman MP, Goldstein RE, Labato MA, et al. ACVIM small animal consensus statement on Lyme disease in dogs: diagnosis, treatment, and prevention. J Vet Intern Med 2006; 20:422-434.
2. Littman MP. Canine borreliosis. Vet Clin N Am (Small Animal) 2003; 33:827-862.
3. Grauer GF, Burgess EC, Cooley AJ, et al. Renal lesions associated with Borrelia burgdorferi infection in the dog. J Am Vet Med Assoc 1988; 193:237-239.
4. Magnarelli LA, Anderson JF, Schreier AB, et al. Clinical and serologic studies of canine borreliosis. J Am Vet Med Assoc 1987; 191:1089-1094.
5. Magnarelli LA, Anderson JF, Schreier AB. Persistence of antibodies to Borrelia burgdorferi in dogs on New York and Connecticut. J Am Vet Med Assoc 1990; 196:1064-1068.
6. Frank JC. Taking a hard look at Borrelia burgdorferi. J Am Vet Med Assoc 1989; 194:1521.
7. Levy SA, Magnarelli LA. Relationship between development of antibodies to Borrelia burgdorferi in dogs and the subsequent development of limb/joint borreliosis. J Am Vet Med Assoc 1992; 200:344-347.
8. Dambach DM, Smith CA, Lewis RM, et al. Morphologic, immunohistochemical, and ultrastructural characterization of a distinctive renal lesion in dogs putatively associated with Borrelia burgdorferi infection: 49 cases (1987-1992). Vet Pathol 1997; 34:85-96.
9. Sanders NA. Canine ''Lyme nephritis.'' Proc 18th ACVIM Forum 2000; 627-628.
10. Goldstein RE. Lyme disease, In: Ettinger SJ, Feldman EC. eds. Textbook of Veterinary Internal Medicine, 7th edn. St. Louis: Saunders Elsevier; 2010, pp. 868-875.
11. Goldstein RE. Current understanding of Lyme nephropathy. Proc 25th ACVIM Forum 2007; 672-673.
12. Goldstein RE, Cordner AP, Sandler JL, et al. Microalbuminuria and comparison of serologic testing for exposure to Borrelia burgdorferi in nonclinical Labrador and Golden Retrievers. J Vet Diagn Invest 2007; 19:294-297.
13. Hutton TA, Goldstein RE, Njaa BL, et al. Search for Borrelia burgdorferi in kidneys of dogs with suspected "Lyme nephritis." J Vet Intern Med 2008; 22:860-865.
14. Chou J, Wunschmann A, Hodzic E, et al. Detection of Borrelia burgdorferi DNA in tissues from dogs with presumptive Lyme borreliosis. J Am Vet Med Assoc 2006; 229:1260-1269.
15. Nangaku M, Couser WG. Mechanisms of immune-deposit formation and the mediation of immune renal injury. Clin Exp Nephrol 2005; 9:183-191.
16. Alchi B, Jayne D. Membranoproliferative glomerulonephritis. Pediatr Nephrol 2010; 25:1409-1418.
17. Erdbruegger U, Dooley MA, Falk RJ. New insights into mechanisms of immune-mediated glomerular disease. Drug Discovery Today 2004; 1:73-81.
18. Lopez-Novoa JM, Rodriguez-Pena AB, Ortiz A, et al. Etiopathology of chronic tubular, glomerular and renovascular nephropathies: clinical implications. J Translational Med 2011; 9:13.
19. Stevenson B, El-Hage N, Hines MA, et al. Differential binding of host complement inhibitor factor H by Borrelia burgdorferi Erp surface proteins: a possible mechanisms underlying the expansive host range of Lyme disease spirochetes. Infect Immunol 2002; 70:491-497.
20. Dorward DW, Schwan TG, Garon CF. Immune capture and detection of Borrelia burgdorferi antigens in urine, blood, or tissues from infected ticks, mice, dogs and humans. J Clin Microbiol 1991; 29:1162-1170.
21. Chang YF, Straubinger RK, Jacobson RH, et al. Dissemination of Borrelia burgdorferi after experimental infection in dogs. J Spirochetal Tick-Borne Dis 1996; 3:80-86.
22. Appel MJG, Allen S, Jacobson RH, et al. Experimental Lyme disease in dogs produces arthritis and persistent infection. J Infect Dis 1993; 167:651-664.
23. Bushmich SL. Lyme disease: Comparative aspects. Proc 18th ACVIM Forum 2000; 203-205.
24. Bauerfeind R, Kreis U, Weiss R, et al. Detection of Borrelia burgdorferi in urine specimens from dogs by a nested polymerase chain reaction. Zentralbl Bakteriol 1998; 287:347-361.
25. Raveche ES, Schutzer SE, Fernandes H, et al. Evidence of Borrelia autoimmunity-induced component of Lyme carditis and arthritis. J Clin Microbiol 2005; 42:850-856.
26. Steere AC, Drouin EE, Glickstein LJ. Relationship between immunity to Borrelia burgdorferi outer-surface protein A (OspA) and Lyme arthritis. Clin Inf Dis 2011; 52(S3):S259-S265.
27. Gross DM, Forsthuber T, Tary-Lehmann M, et al. Identification of LFA-1 as a candidate autoantigen in treatment-resistant Lyme arthritis. Science 1998; 281:703-706.
28. Kalish RA, Leong JM, Steere AC. Association of treatment-resistant chronic Lyme arthritis with HLA-DR4 and antibody reactivity to OspA and OspB of Borrelia burgdorferi. Infect Immun 1993; 61:2774-2779.
29. Lengl-Janssen B, Strauss AF, Steere AC, et al. The T helper cell response in Lyme arthritis: differential recognition of Borrelia burgdorferi outer surface protein A in patients with treatment-resistant or treatment-responsive Lyme arthritis. J Exp Med 1994; 180:2069-2078.
30. Chen J, Field JA, Glickstein L, et al. Association of antibiotic treatment-resistant Lyme arthritis with T cell responses to dominant epitopes of outer surface protein A of Borrelia burgdorferi. Arthritis Rheum 1999; 42:1813-1822.
31. Akin E, McHugh GL, Flavell RA, et al. The immunoglobulin (IgG) antibody response to OspA and OspB correlates with severe and prolonged Lyme arthritis and the IgG response to P35 correlates with mild and brief arthritis. Infect Immun 1999; 67:173-181.
32. Guerau-de-Arellano M, Huber BT. Development of autoimmunity in Lyme arthritis. Curr Opin Rheumatol 2002; 14:388-393.
33. Hu LT, Klempner MS. Host-pathogen interactions in the immunopathogenesis of Lyme disease. J Clin Immunol 1997; 17:354-365.
34. Philipp MT. Studies on OspA: a source of new paradigms in Lyme disease research. Trends Microbiol 1998; 6:44-47.
35. Sigal LH. Lyme disease: a review of aspects of its immunology and immunopathogenesis. Ann Rev Immunol 1997; 15:63-92.
36. Sigal LH. Immunologic mechanisms in Lyme neuroborreliosis: the potential role of autoimmunity and molecular mimicry. Semin Neurol 1997; 17:63-68.
37. Straubinger RK, Straubinger AF, Summers BA, et al. Borrelia burgdorferi induces the production and release of proinflammatory cytokines in canine synovial explant cultures. Infect Immun 1998; 66:247-258.
38. Singh SK, Girschick HJ. Toll-like receptors in Borrelia burgdorferi-induced inflammation. Clin Microbiol Infect 2006; 12:705-717.
39. Maloy AL, Black RD, Sagurola RJ. Lyme disease complicated by the Jarisch-Herxheimer reaction. J Emerg Med 1998; 16:437-438.
40. Simon D, Finn L, Eddy A. Subepithelial humps and microthrombi: looking for a mechanism. A J Kidney Dis 2006; 47:365-370.
41. Greene RT, Levine JF, Breitschwerdt EB, et al. Clinical and serologic evaluations of induced Borrelia burgdorferi infection in dogs. Am J Vet Res 1988; 49:752-757.
42. Cerri D, Farina R, Andreani E, et al. Experimental infection of dogs with Borrelia burgdorferi. Res Vet Sci 1994; 57:256-258.
43. Straubinger RK, Straubinger AF, Summers BA, et al. Clinical manifestations, pathogenesis, and effect of antibiotic treatment on Lyme borreliosis in dogs. Wien Klin Wochenschr 1998; 110:874-881.
44. Straubinger RK, Straubinger AF, Härter L, et al. Borrelia burgdorferi migrates into joint capsules and causes an up-regulation of interleukin-8 in synovial membranes of dogs experimentally infected with ticks. Infect Immun 1997; 65:1273-1285.
45. Straubinger RK, Summers BA, Chang YF, et al. Persistence of Borrelia burgdorferi in experimentally infected dogs after antibiotic treatment. J Clin Microbiol 1997; 35:111-116.
46. Straubinger RK, Straubinger AF, Summers BA, et al. Status of Borrelia burgdorferi infection after antibiotic treatment and the effects of corticosteroids: an experimental study. J Infect Dis 2000; 181:1069-1081.
47. Straubinger RK. PCR-based quantification of Borrelia burgdorferi organisms in canine tissues over a 500-day postinfection period. J Clin Microbiol 2000; 38:2191-2199.
48. Liang FT, Jacobson RH, Straubinger RK, et al. Characterization of a Borrelia burgdorferi VlsE invariable region useful in canine Lyme disease serodiagnosis by enzyme-linked immunosorbent assay. J Clin Microbiol 2000; 38:4160-4166.
49. Harter L, Straubinger RK, Summers BA, et al. Upregulation of inducible nitric oxide synthase mRNA in dogs experimentally infected with Borrelia burgdorferi. Vet Immuno Immunopathol 1999; 67:271-284.
50. Callister SM, Jobe DA, Schell RF, et al. Detection of borreliacidal antibodies in dogs after challenge with Borrelia burgdorferi-infected Ixodes scapularis ticks. J Clin Microbiol 2000; 38:3670-3674.
51. Chang YF, Novosel V, Chang CF, et al. Experimental induction of chronic borreliosis in adult dogs exposed to Borrelia burgdorferi-infected ticks and treated with dexamethasone. Am J Vet Res 2001; 62:1104-1112.
52. McCausland FR, Niedermaier S, Bijol V, et al. Lyme disease-associated glomerulonephritis. Nephrol Dial Transplant 2011; 26:3054-3056.
53. Kirmizis D, Chatzidimitriou D. Comment on "Membranous glomerulonephritis secondary to Borrelia burgdorferi infection presenting as nephrotic syndrome." Nephrol Dial Transplant 2010; 25:1723-1727.
54. Papineni P, Doherty T, Pickett T, et al. Membranous glomerulonephritis secondary to Borrelia burgdorferi infection presenting as nephrotic syndrome. Nephrol Dial Transplant Plus 2010; 3:105-106.
55. Kirmizis D, Efstratiadis G, Economidou D, et al. MPGN secondary to Lyme disease. Am J Kidney Dis 2004; 43:544-551.
56. Kelly B, Finnegan P, Cormican M, et al. Lyme disease and glomerulonephritis. Ir Med J 1999; 92:372-373.
57. Littman MP. Protein losing nephropathy in small animals. Vet Clin N Am (Small Animal) 2011:41:31-62.
58. Wang JY, Wang SS, Yin PZ. Haemolytic-uraemic syndrome caused by a non-O157:H7 Escherichia coli strain in experimentally inoculated dogs. J Med Microbiol 2006; 55:23-29.
59. Dell'Orco M, Bertazzolo W, Pagliaro L, et al. Hemolytic-uremic syndrome in a dog. Vet Clin Pathol 2005; 34:264-269.
60. Chantrey J, Chapman PS, Patterson-Kane JC. Haemolytic-uraemic syndrome in a dog. J Vet Med 2002; 49:470-472.
61. Holloway S, Senior D, Roth L, et al. Hemolytic uremic syndrome in dogs. J Vet Intern Med 1993; 7:220-227.
62. Scheiring J, Andreoli SP, Zimmerhackl LB. Treatment and outcome of Shiga-toxin-associated hemolytic uremic syndrome (HUS). Pediatr Nephrol 2008; 23:1749-1760.
63. Levy SA, O'Connor TP, Hanscom JL, et al. Quantitative measurement of C6 antibody following antibiotic treatment of Borrelia burgdorferi antibody+ nonclinical dogs. Clin Vacc Immunol 2008; 15:115-119.
64. Ohnishi J, Piesman J, deSilva AM. Antigenic and genetic heterogeneity of Borrelia burgdorferi populations transmitted by ticks. Proc Natl Acad Sci USA 2001; 98:670-675.
65. Liang FT, Nelson FK, Fikrig E. Molecular adaptation of Borrelia burgdorferi in the murine host. J Exp Med 2002; 196:275-280.
66. Guerra MA, Walker ED, Kitron U. Canine surveillance system for Lyme borreliosis in Wisconsin and northern Illinois: geographic distribution and risk factor analysis. Am J Trop Med Hyg 2001; 65:546-552.
67. Philipp MT, Bowers LC, Fawcett PT, et al. Antibody response to IR6, a conserved immunodominant region of the VlsE lipoprotein, wanes rapidly after antibiotic treatment of Borrelia burgdorferi infection in experimental animals and in humans. J Infect Dis 2001; 184:870-878.
68. Littman MP. Diagnosis of infectious diseases of the urinary tract, In: Bartges J, Polzin DJ. eds. Nephrology and Urology of Small Animals. Hoboken: Wiley-Blackwell; 2011, pp. 241-252.
69. Zatelli A, Paltrinieri S, Nizi F, et al. Evaluation of a urine dipstick test for confirmation or exclusion of proteinuria in dogs. Am J Vet Res 2010; 7:235-240.
70. Nabity MB, Boggess MM, Kashtan CE, et al. Day-to-day variation of the urine protein:creatinine ratio in female dogs with stable glomerular proteinuria caused by X-linked hereditary nephropathy. J Vet Intern Med 2007; 21:425-430.
71. LeVine DN, Zhang DW, Harris T, et al. The use of pooled vs. serial urine samples to measure urine protein:creatinine ratios. Vet Clin Pathol 2010; 39:53-56.
72. Lees GE, Brown SA, Elliott J, et al. Assessment and management of proteinuria in dogs and cats: 2004 ACVIM Forum Consensus Statement (small animal). J Vet Intern Med 2005; 19:377-385.
73. Slade DJ, Lees GE, Berridge BR, et al. Resolution of a proteinuric nephropathy associated with Babesia gibsoni infection in a dog. J Am Anim Hosp Assoc 2011; 47:e138-e144.
74. Beall MJ, Chandrashekar R, Eberts MD, et al. Serological and molecular prevalence of Borrelia burgdorferi, Anaplasma phagocytophilum, and Ehrlichia species in dogs from Minnesota. Vector Borne Zoonotic Dis 2008; 8:455-464.
75. Smith BE, Tompkins MB, Breitschwerdt EB. Antinuclear antibodies can be detected in dog sera reactive to Bartonella vinsonii subsp. berkhoffii, Ehrlichia canis, or Leishmania infantum antigens. J Vet Intern Med 2004; 18:47-51.
76. Gerber B, Haug K, Eichenberger S, et al. Follow up of Bernese Mountain dogs and other dogs with serologically diagnosed Borrelia burgdorferi infection: what happens to seropositive animals? BMC Vet Res 2009; 5:18.
77. Gerber B, Eichenberger S, Haug K, et al. Association of urine protein excretion and infection with Borrelia burgdorferi sensu lato in Bernese Mountain dogs. Vet J 2009; 182:487-488.
78. Vaden SL, Littman MP, Cianciolo RE. Familial renal disease in Soft-coated Wheaten terriers. J Vet Emerg Crit Care 2013; 23:174-183.
79. Littman MP, Wiley CA, Raducha MG, et al. Glomerulopathy and mutations in NPHS1 and KIRREL2 in soft-coated Wheaten Terrier dogs. Mamm Genome 2013;DOI 10.1007/s00335-012-9445-8.
80. Littman MP. A matter of opinion: should we treat asymptomatic, nonproteinuric Lyme-seropositive dogs with antibiotics? Clin Brief 2011; 9:13-16.
81. Scindia YM, Deshmukh US, Bagavant H. Mesangial pathology in glomerular disease: targets for therapeutic intervention. Adv Drug Delivery Rev 2010; 62:1337-1343.
82. Vaden SL, Breitschwerdt EB, Armstrong PJ, et al. The effects of cyclosporine versus standard care in dogs with naturally occurring glomerulonephritis. J Vet Intern Med 1995; 9:259-266.
83. Topfer KH, Straubinger RK. Characterization of the humoral immune response in dogs after vaccination against the Lyme borreliosis agent: a study with five commercial vaccines using two different vaccination schedules. Vaccine 2007; 25:314-326.
84. Moore GE, Guptill LF, Ward MP, et al. Adverse events diagnosed within three days of vaccine administration in dogs. J Am Vet Med Assoc 2005; 227:1102-1108.
85. Lim LC, England DM, DuChateau BK, et al. Development of destructive arthritis in vaccinated hamsters challenged with Borrelia burgdorferi. Infect Immun 1994; 62:2825-2833.
86. Croke CL, Munson EL, Lovrich SD, et al. Occurrence of severe destructive Lyme arthritis in hamsters vaccinated with outer surface protein A and challenged with Borrelia burgdorferi. Infect Immun 2000; 68:658-663.
87. Gondolf KB, Mihatsch M, Curschellas E, et al. Induction of experimental allergic arthritis with outer surface proteins of Borrelia burgdorferi. Arthritis Rheum 1994; 37:1070-1077.
88. D'Agati VD, Kaskel FJ, Falk RJ. Focal segmental glomerulosclerosis. N Engl J Med 2011; 365:2398-2411.